Timeline How the Center for Biodefense and Emerging Infectious Diseases Evolved


Award

2016

NIH/NIAID awards the Fogarty International Center training program grant on the impact of zoonotic and vector-borne viruses, rickettsiae, and Leptospira in acute undifferentiated febrile illnesses.

  
Award

2014

NIH/NIAID awards the Center of Excellence for Translational Research U19 grant "Advancement of Treatments for Ebola and Marburg Virus Infections"

  
Head

2010

Dr. Peter Melby joins UTMB and heads Center for Tropical Diseases.

  
Location

2009

NIH/NIAID the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (WRCE) grant renewed.

  
Location

2008

Galveston National Laboratory opens.

  
Lab

2004

The Robert E. Shope, MD, Laboratory in the John Sealy Pavilion for Infectious Diseases Research commissioned; Institute for Human Infections and Immunity (IHII) established

  
Movie

2003

WRCE and GNL awards made; Center for Biodefense and Emerging Infectious Diseases established; The Robert E. Shope, MD Laboratory dedicated

  
Movie

2002

NIAID Hepatitis Antiviral contract & NIAID Emerging Infectious Disease Research contract awarded; BSL4 lab ground-breaking

  
Movie

2001

UTMB Center for Biodefense established; Sept. 11 and anthrax attacks occur

  
Movie

1997

WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research established; DARPA biodefense grant awarded; UTMB President Dr. Jack Stobo endorses concept of constructing BSL4 lab on campus

  
Movie

1996

Strategy for developing BSL4 lab proposed by Dr. David Walker

  
Head

1995

WHO Collaborating Center for Tropical Diseases established; Drs. Robert Tesh and Robert Shope relocate from Yale University; World Reference Center for Arboviruses established

  
Lab

1994

Center for Tropical Diseases established

  
Lab

1991

Concept of Center for Tropical Diseases proposed

  

Site managed by the CBEID

Top